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Renal functional reserve in cyctosporin-treated recipients of kidney
transplant. The aims of this study were to determine whether renal
functional reserve (RFR) is still present in cyclosporin-treated renal
transplant recipients, and to examine the relationship between RFR and
proximal reabsorption. A serial study was carried out in 12 renal
allograft recipients (R) with good renal graft function at 20 2.5 days
(SI) and at 7.6 0.4 months (S2) post-transplantation, and the results
were compared to those in eight subjects who had undergone unine-
phrectomy (one-kidney controls: UNx.C) and in 12 healthy volunteers
(two-kidney controls: 2K.C). R and C were in similar sodium and
protein balance and with similar plasma renin and aldosterone levels. R
had normal serum creatinine level on moderate doses of cyclosporin
(whole blood cyclosporin concentration: 212 20 and 125 20 nglml at
Sl and S2, respectively). Eight one-hour clearance periods were
performed prior to, during and following a three-hour i.v, infusion of a
mixture of 201-amino acids (Azonutril 25®, 4.5mg amino acids/kg/mm).
Baseline glomerular filtration rate (GFR) was lower in recipients at Si
and S2 (55 5 and 54 4 mI/mm/i .73 m2, respectively) than in UNx.C
and 2K.C (72 4 and 113 4 mI/min/! .73 m2, respectively, P < 0.05
and 0.001). Amino acid infusion elicited significant GFR increases in
controls as well as in recipients in spite of higher renal vascular
resistances (RVR). The greater measured increase in GFR, which
represented RFR, was 18 3 and 28 2 ml/min/l.73 m2 in UNx.C and
2K.C, respectively (P < 0.001), and 17 3 mllminll.73 m2 in Rat both
SI and S2 (P < 0.001). Contrary to both UNx and 2K controls, the
acute hyperfiltration in R at Si and S2 occurred with a significant
increase in effective renal plasma flow, no alteration in filtration fraction
and a large decrease (approximately 20 and 17%) in RVR while no
correlation could be detected between the RFR and baseline GFR.
Baseline lithium clearance, used as a marker of overall proximal fluid
delivery (CLI), was significantly lower, whereas baseline fractional
excretion of lithium (FELl) was significantly higher in Rat Si and S2 and
in UNx.C (41 4, 40 3 and 38 3%, respectively) than in 2K.C (31
2%, P < 0.05). Consistent and significant increases in CLI, FELl and
absolute proximal reabsorption occurred both in R at S 1 and S2 and in
UNx and 2K controls during elicitation of RFR. These results indicate
that: (1) renal graft recipients maintained on cyclosporin therapy do not
exhibit permanent glomerular hyperfiltration, since they retain a RFR
until at least eight months post-transplantation which represents ap-
proximately 30% of the baseline GFR but do, however, demonstrate a
particular pattern of hemodynamic response; (2) in one-kidney recipi-
ents and controls, the clearance of lithium is proportionally less reduced
than GFR, and baseline fractional proximal reabsorption is thus lower
than in two-kidney controls; and, (3) the acute increase in GFR induced
by amino acid infusion does not involve a decrease in delivery of fluid
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from the proximal nephron that could account for any possible reduc-
tion in the tubuloglomerular feedback activity.
There is general agreement that the propensity of cyclosporin
A to induce nephrotoxicity is a drawback for its use in the
prevention of rejection in organ transplantation. Two main
forms of nephrotoxicity have been recognized [1, 2]. The first is
an acute renal functional impairment that commonly occurs in
the first few weeks or months after transplantation. It chiefly
results from vasoconstnction and alterations in renal hemody-
namics. It is usually mild and reversible upon reduction in
dosage or withdrawal of the drug. The second form is a
progressive and irreversible impairment of nephron function
following long-term exposure without overt evidence of rejec-
tion. The mode of a possible transition from the first to the
second form during long-term therapy has not been determined
precisely.
The healthy kidney has the ability to increase glomerular
filtration rate (GFR) during oral protein load [3, 4] or amino acid
and/or dopamine infusion [5—7]. Renal functional reserve (RFR)
is defined as the difference between basal or "unstimulated"
GFR and "stimulated" GFR increased by such stimuli. RFR
reflects the renal capacity to achieve a higher degree of function
by vasodilation of glomerular arterioles. Whether renal trans-
plant recipients treated with cyclosporin still have a normal
response and a RFR deserves further attention since altered
renal hemodynamics play a major role in cyclosponn-induced
decrease in basal GFR. Indeed, recent studies have suggested
that cyclosporin suppresses the graft's ability to demonstrate a
RFR after either an oral protein load [8, 9] or an intravenous
amino acid infusion [10, 11]. Complete absence of functional
reserve may imply that the residual nephrons are working at
maximal capacity, perhaps heralding a supplementary fall in
basal GFR and a supplementary rise in plasma creatinine [3,
12]. Such a glomerular hyperfiltration may play a central role in
the progression of renal damage [12] and the loss of the
so-called RFR may express the first step in the deterioration of
renal function. However, in the previous studies, time after
transplantation was either not precisely stated [8, 10] or very
heterogeneous [9, 11]. This and some reports that a RFR
(assessed only by creatinine clearance) may be maintained in
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Table 1. Body weight and surface area, serum creatinine, 24-hour urine Na and K, and urine urea nitrogen (UUN) in kidney recipients 1
month (R-Sl) and 8 months (R-S2) after transplantation, in uninephrectomized controls (UNx.C) and in healthy two-kidney controls (2K.C)
R-Sl R-S2 UNx.C 2K.C
Body weight kg
Body surface area m2
Creatinine mg/dl
62.6 2.4
1.70 0.03
1.04 0.06"
67.6 2.8
1.74 0.03
1.09 0.07k
66.0 4.4
1.73 0.06
1,10 0.09"
60.3 2.3
1.69 0.04
0.80 0.03
UNa mEqlday 144 16 150 25 137 22 158 14
UK mEqiday 72 7 72 8 57 12 61 7
UUN glday 13.3 1.0 12.7 0.7 11.3 1.3 12.4 1.2
Values are expressed as means SE.
a P < 0.001 vs. 2K.C
b P < 0.01 vs. 2K.CP < 0.01 vs. R-S1
transplanted patients on cyclosporin therapy [13, 14] prompted
us to re-examine this question in the same group of cyclosporin-
treated renal transplant recipients studied serially at two times
post-transplantation.
Several mechanisms may play a role in the elicitation of RFR
in healthy humans [15, 16]. One is an alteration of tubuloglom-
erular feedback. Experimental studies on animals have pro-
vided several lines of evidence indicating that the activity of
tubuloglomerular feedback is decreased during both an amino
acid-induced hyperfiltration and a long-lasting administration of
a protein-rich diet. This has been ascribed to an enhanced
reabsorption of sodium and chloride before the early distal
tubule leading to a lower signal at the macula densa [6, 17—20].
Such a reduction of negative feedback control on glomerular
hemodynamics may induce a preglomerular vasodilation allow-
ing GFR to rise. This postulated scheme implies an increased
sodium and chloride reabsorption upstream of the macula densa
for eliciting RFR. On the other hand, cyclosporin may, by itself,
alter renal tubule function. In this regard, it has been suggested
that the mechanism responsible for the frequent cyclosporin-
associated hypertension may be sodium retention [21], and a
recent study has demonstrated that chronic cyclosporin admin-
istration to dogs results in a positive daily sodium balance and,
also, an attenuation of the natriuretic and diuretic response to
acute volume expansion [22]. Most information regarding tubu-
lar function integrity during cyclosporin administration has
been gleaned utilizing lithium as a clearance marker for proxi-
mal tubular function. In animals [23, 24] as well as in humans
[25, 26], cyclosporin administration was reported to decrease
absolute and fractional lithium clearance and to increase prox-
imal fractional reabsorption. These results have suggested that
cyclosporin tubular effects may partly be a functional response
to the reduction in glomerular filtration pressure and/or rate.
Nevertheless, the alteration in tubular function induced by
cyclosporin administration may obviously interfere with the
acute intrarenal mechanism brought into play in normal sub-
jects by an amino acid infusion. Whether the tubular effects of
cyclosporin alter the ability of transplanted kidneys to acutely
increase their proximal reabsorption and thereby to demon-
strate a RFR has not been examined.
Therefore, the aims of this study were: (a) to determine
whether renal functional reserve (evaluated during an amino
acid i.v. infusion) is still present in renal transplant recipients
maintained on cyclosporine therapy at one month and eight
months after transplantation; (b) to examine the relationship
between RFR and proximal reabsorption (by using the clear-
ance of lithium as a marker of overall proximal fluid delivery
during amino acid infusion) and to seek abnormalities in the
tubular mechanism triggering RFR in renal transplant recipi-
ents. With these aims in mind, the response of transplanted
kidneys to amino acid infusion was compared to that of both
normal kidneys in healthy volunteers and remnant kidneys in
subjects who had undergone uninephrectomy.
Methods
Subjects
The study (previously approved by the ethical review board
of the Centre Hospitalier Universitaire de Toulouse) was car-
ried out in 12 renal transplant recipients (R), in eight subjects
who had been previously uninephrectomized (one-kidney or
uninephrectomized controls: UNx.C) and in 12 healthy volun-
teers (two-kidney controls: 2K.C).
Recipients (7 males, S females) were submitted twice to the
study protocol, average times after having received a cadaveric
renal transplant being 20.0 2.5 days for the first study (Si) and
7.6 0.4 months for the second (S2). Their mean age was 52.1
2.1 years (range 26.6 to 64.3 years) at Si. Their body surface
area increased slightly from S 1 to S2 due to similar increases in
body weight (4.9 1.4 kg, P < 0.01; Table 1). Initial renal
diseases were 3 interstitial nephritis, 2 cystic diseases of the
kidney, 2 IgA nephropathies, 2 vascular nephro-angiosclerosis,
1 primary amyloidosis and 2 undetermined chronic glomerulo-
nephritis. Mean duration of hemodialysis prior to transplanta-
tion was 50.0 8.8 months. All patients were receiving their
first renal allograft except one who was receiving a second graft
after a chronic rejection of the first transplant. Mean age of
kidney donors was 31.0 2.6 years and mean duration of renal
graft cold ischemia was 26 1 hours. Two clinical rejection
episodes occurred in one recipient two and four months after
transplantation, and one in another recipient seven months after
transplantation, that is, between the first and the second studies
in both patients. All were receiving maintenance immunosup-
pressive therapy with azathioprine, prednisone and cyclospo-
rin. From S 1 to S2, daily azathioprine dosage was reduced from
1.4 0.1 to 0.8 0.1 mg/kg body wt (P < 0.05) and daily
prednisone dosage from 0.80 0.04 to 0.20 0.02 mg/kg body
wt (P < 0.001). All patients' treatment was switched from
polyclonal antithymocyte serum to cyclosporin five to eight
days after transplantation when serum creatinine had decreased
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Fig. 5. Effects of EGTA and thapsigaigin on the temporal and spatial changes in cytosolic [Ca + ], andnuclear [Ca +] after stimulation with Ang II (1O
Ac) in [Ca]-containing medium. Diagram is as described in Figure 3A. Stimulation with Ang II in calcium-free medium (10 mM EGTA, B) resulted
in a decrease of the initial [Ca] peak while the [Ca]0 values were not altered compared to control experiments with Ang II in [Ca]-contaMing
medium. Preincubation of the vascular smooth muscle cells with thapsigargin (10_6 M for 10 mm) reduced both the [Ca] and [Ca] signals to a
similar extent (C). When both [Ca] release and extracellular [CaJ influx were prevented by the combination of EGTA (10 mM) and thapsigargin
(10—6 M for 10 mm), stimulation with Ang II elicited no [Ca'] signal in either the nucleus or the cytosol (Representative experiment out of 12).
experimental conditions in Figure 6B. Neither staurosporine nor
the protein kinase C inhibitor H7 had any effect on the response
to Ang II.
Discussion
These experiments show that the stimulation of vascular
smooth muscle cells causes an excitation of Ca within the
cytoplasm with a spreading wave towards the nucleus and periph-
ery of the cell. The changes in the [Ca] concentration were
immediately followed by a Ca transient in the nucleus which
reversed the cytosolic/nuclear calcium gradient and exceeded the
calcium rise in the cytoplasm. Within 80 seconds, the cells
returned to their basal state, with [Cat again exceeding[Ca ] values. The same pattern was observed when Ca +
inflow was stimulated with KC1 or with Ca ionophores. The
nuclear responses to these agents was only slightly enhanced when
the Ca + concentration of the medium was increased. We also
found that by placing the cells in a Ca -free medium, the
[CC and [CC ] responses were reduced. Furthermore, the
differences in magnitude of the [Ca] and [Ca] transients
after Ang II were no longer seen. We observed a similar effect
when the cells were treated with the CC + channel blocker
nitrendipine prior to stimulation with Ang II. When thapsigargin,
an inhibitor of the [Ca]-(Mg)-adenosine-triphosphatase
(ATP) of the endo(sarco)plasmic reticulum was given, the in-
creases in [CC ] and [CC ] were both attenuated. However,
the relationships between [CC ] and [CC ] were unchanged.
A CC k-free medium, which precluded calcium influx, plus
thapsigargin, which prevented release of calcium from stores,
abolished both the [Ca] and [Ca1 responses to Ang II
altogether. In addition, we could find no effect of protein kinase C
inhibition on the Ang Il-induced [Ca] signaling. Our obser-
vations demonstrate that the Ang IT-induced rise in the [CC ],,
concentration is triggered by the changes in the [Ca] concen-
tration, while the concomitant 1P3 production and the protein
kinase activation seem to have no influence.
Our first observation was that the [CC concentration and
the [Ca] concentration are regulated independent of one
another in VSMC. Under non-stimulated conditions, VSMC
showed low [CC ] values. This finding indicates that in resting
cells, a nuclear/cytoslic gradient is maintained to keep the
[Ca] concentrations at low levels. This phenomen has been
decribed before in the Ar7 smooth muscle cell line by Himpens et
al [2] and also by Williams et al [8]. Himpens et al [2] also found
that upon stimulation of their cells this gradient was reversed in
that the [Ca] concentration increased out of proportion to the
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kits®, Pasteur-Sanofi, Marne-la-Coquette, France) and aldoste-
rone concentration (RIA with ALDO II kits®, Sorin Biomedica,
Saluggia, Italy) were measured in plasma samples from the last
clearance periods before, during and after amino acid infusion.
Glomerular filtration rate (GFR) was equated with the clear-
ance of inulin (C1,,), and effective renal plasma flow (ERPF)
with the clearance of PAH (CPAH). RFR was equated with the
difference between the higher GFR measured during amino acid
infusion and baseline GFR. The filtration fraction was calcu-
lated as the ratio of C1,, to CPAH. Renal blood flow (RBF) was
calculated as the ratio of ERPF to l-hematocrit and renal
vascular resistances (RVR) were calculated as the ratio of mean
AP mm Hg to RBF liter/mm. The delivery of fluid from the
proximal tubules to distal nephron segments, that is, absolute
proximal excretion (APE), was equated with the clearance of
lithium (CLI). Fractional proximal excretion (FPE) was equated
with the fractional excretion of lithium (FELl) and calculated as
the ratio of APE to GFR. Absolute proximal reabsorption
(APR) was calculated as GFR minus APE. All rates of filtration,
flow, excretion and reabsorption as well as renal vascular
resistances were expressed per 1.73 m2 of body surface area.
All fractional data were expressed as percentages.
Reported data before (baseline) and after (recovery) amino
acid infusion represent the mean of two and three consecutive
clearance periods, respectively. Unless otherwise specified,
reported data during amino acid infusion (stimulation) represent
the values obtained during the single period of the higher level
of GFR stimulation because RFR was calculated as the differ-
ence between GFR during this period and baseline GFR. This
period of stimulated higher GFR was more often than not the
last amino acid infusion period (10 times in R at Si, 8 times in
R at S2, 8 times in UNx.C and 7 times in 2K.C) with a slightly
but not significantly later greater increase in recipients than in
controls. The values reported represent means SE. Changes
in recipients and in controls were analyzed using the Student's
t-test for paired samples. Differences between recipients,
UNx.C and 2K.C were analyzed using the Student's t-test for
unpaired variables. Best-fit linear regression was evaluated
using the least-squares method. Results with P < 0.05 were
considered statistically significant.
Results
Baseline GFR in recipients at Si and S2 (55 5 and 54 4
mi/mm, respectively) was significantly lower than in UNx.C (72
4 mllmin, P < 0.05) and 2K.C (113 4 ml/min, P < 0.001;
Fig. 1). The average increase in GFR during amino acid infusion
was very significant (P < 0.001) in recipients at S1(ii 3
mi/mm) and S2 (8 2 mI/mm) as well as in UNx.C (13 3
mi/mm) and in 2K.C (19 2 mL'min). Stimulated higher GFR
values during amino acid infusion were also lower in the
recipients (P < 0.01 vs. UNx.C and P < 0.001 vs. 2K.C), being
72 5 mI/mm in R at Si, 71 6 mI/mm in R at S2, 90 2
mi/mm in UNx.C, and 142 3 mI/mm in 2K.C (Fig. 1). Neither
unstimulated nor stimulated GFR significantly differed at Si or
S2 between hypertensive recipients and the whole group of
recipients or the normotensive recipients. Thus, RFR was 17
3 mI/mm in recipients at both Si and S2, which was very similar
to the value in UNx.C (18 3 mI/mm) and lower than the value
in 2K.C (28 2 ml/min, P < 0.001). Remarkably, when
expressed as a percentage of respective baseline GFR, RFR
b
E
E
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Fig. 1. Glomerular filtration rate (C,,,: clearance of maim) before
(baseline: U), during (stimulated higher GFR: 0) and after (recovery:) amino acid infusion in 12 renal transplant recipients either 20.0
2.5 days (R-S1) or 7.6 0.4 months (R-S2) after transplantation, in 8
uninephrectomized controls (UNx.C), and in 12 healthy two-kidney
controls (2K.C). Values represent means SE. Circles represent
significant differences compared to baseline 2K.C values (°°°P <
0.001). Asterisks represent significant differences compared to respec-
tive baseline values (*** P < 0.001).
was greater in transplant recipients at both Si (30%) and S2
(3 1%) than in UNx and 2K control subjects (25%). Amino
acid-induced stimulation was reversible, as evidenced by the
fact that there was no difference in GFR between baseline and
recovery values (Fig. 1).
Simple linear regression indicated that stimulated higher GFR
was significantly correlated to baseline GFR in all groups (r =
0.84forRatSl,P<0.OOl;r=0.9lforRatS2,P<0.001;r=
0.73 for UNx.C, P < 0.05; and r = 0.85 for 2K.C, P < 0.001)
with a steeper slope of the regression line in recipients at Si
(P < 0.05) and at S2 (P < 0.001) than in 2K.C, and a gentler
slope in UNx.C (P < 0.05; Fig. 2). On the other hand, RFR was
significantly and inversely correlated to baseline GFR in both
UNx and 2K controls (r = 0.92 and 0.76, respectively, P < 0.01)
with a steeper slope in UNx.C (P < 0.05), indicating that the
lower the GFR, the higher the RFR was in both controls. In
contrast, such a correlation could not be detected in recipients
either at Si or at S2 (Fig. 2), indicating that RFR is independent
of baseline GFR in transplant recipients. No other significant
correlation was observed in recipients or controls between RFR
and baseline arterial pressure, renal plasma flow, renal resis-
tances, filtration fraction, sodium excretion or lithium clear-
ance.
Data for mean arterial pressure, effective renal plasma flow,
filtration fraction and renal vascular resistances are presented in
Table 2. Baseline ERPF in recipients at Si and S2 and in
UNx.C was significantly lower than in 2K.C. During stimula-
tion, ERPF increased significantly in R at Si (by 57 18
mllmin, P < 0.01) and at S2 (by 41 8 mI/mm, P <0.001), but
not in UNx.C (by 10 10 mI/mm) or in 2K.C (by Si 24
mI/mm). Thus, FF in recipients was not significantly altered at
Si or at S2 during amino acid infusion due to simultaneous GFR
and ERPF increases. In contrast, FF increased by 5.4 1.3 and
3.6 1.0% in UNx.C and 2K.C, respectively (P < 0.01), due to
*
*
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60
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0
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Ader et a!: RFR in renal graft recipients 1661
A
2K.C
£
Table 3. Effects of AA infusion (stimulation) on urine flow rate (V),
sodium excretion (UNaV), fractional sodium excretion (FENa), osmolar
clearance (Com) and free water clearance (CH o) in kidney recipients 1
month (R-Sl) and 8 months (R-S2) after transpkntation, in uninephrec-
tomized controls (UNx.C), and in healthy two-kidney controls (2K.C)
Baseline Stimulation Recovery
RS2***
cr
LL0
150
120
90
UNx.C* V mi/mmR-Sl
R-S2
UNx.C
2K.C
6.1 0.7
6.0 0.6
5,9 0.7
6.1 0.7
6.5 0.3
7.0 0.5
5.8 0.6
5.9 0.7
7.0 0.3
6.4 0.3
6.1 0.5
7.4 0.4
'
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E
—
E E
i5
60
30
0
0
UNaV pEqlmin
R-Sl
R-S2
UNx.C
2K.C
FENa%
R-Sl
R-S2
UNx.C
2K.C
Csm mi/mm
R-S1
180 35
150 22
175 28
190 22
2.6 0.4b
2.2 0.4
1.8 0.3
1.2 0.1
2,9 0.4
280 38"
260 54"270 35280 l9
3.2 0.5C
2.8 0.?
2.2 0.3a
1.5 0.1"
4.3 o.4
270 24"
210 23"
240 23"
270 19"
3.6 0.4
2.9 03b,d
2.4 0.3
1.7 o.2
4.1 o.230 60 90 120 150
60. B
UNx.C* 0
R-S2
UNx.C
2K.C
CHO mi/mm
1-S1
R-S2
UNx.C
2K.C
2.5 0.2
3.2 0.3
3.2 0.2
3.1 0.6
3.5 0.5
2.7 0.6
2.9 0.6
4.0 0.?
4.2 03d
4.4 O.2
2.1 0.3
3.0 0.4
1.5 0.6
1.5 0.7
3.3
3.3 0.2"
4.4 0.2"
2.9 0.2
3.2 0.2
2.6 0.3
2.9 0.4
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Fig. 2. Relation between stimulated higher glomerular filtration rate
(GFR, A) or renal functional reserve (RFR, B) during amino acid
infusion and baseline glomerular filtration rate. Mean regression lines
calculated from 12 healthy two-kidney controls (2K.C: 0), 8 uninephrec-
tomized controls (UNx.C: 0) and 12 renal transplant recipients either
20.0 2.5 days (R-S1: A) or 7.6 0.4 months (R-S2: •) after
transplantation. Stimulated higher GFR: y = 0.6x + 76.4, r = 0.85
(2K.C); y = 0.3x + 67.7, r = 0.73 (UNx.C); y = 0.8x + 24.7, r = 0.84
(R-Sl); and y = 1.4x — 2.7, r = 0.91 (R-S2). RFR: y = —0.4x + 76.4,
r = 0.76 (2K.C); and y = —0.7x + 67.7, r = 0.92 (Unx.C). P values(*** P < 0.001, * P < 0.05) represent significant slope differences
compared to two-kidney controls.
the sole increase in GFR with a stable ERPF. Calculated
baseline RVR were higher in recipients than in both UNx and
2K controls, and higher in UNx.C than in 2K.C. RVR were
significantly decreased by amino acid infusion in UNx.C (by
21 9mm Hg/iiter/min . 1.73 m, P <0.05), in 2K.C (by 11
4mm Hg/liter• min' 1.73 m2 ',P <0.05) and in recipients
Values are expressed as means SE.
a P < 0.05 vs. 2K.C
b P < 0.01 vs. 2K.C
P < 0.001 vs. 2K.C
"P < 0.05 vs. Baseline
e P < 0.01 vs. Baseline
<0.001 vs. Baseline
at both Si and S2 (by 57 18 and 48 17 mm Hg!
literS min' . 1.73 ma', P <0.01 andP <0.05, respectively) in
the absence of any significant alteration in AP in both controls
and recipients (Table 2). No significant difference in RVR was
observed between baseline and recovery values in controls or in
recipients.
Table 3 shows the values of urine flow rate (V), sodium
excretion (UNaV), fractional excretion of sodium (FENa), 0S
molar clearance (Csm) and free water clearance (CH20). It is
noteworthy that baseline values for V or for UNaV, Cosm and
C20 did not differ between recipients at Si or S2, UNx.C and
2K.C. As expected, baseline FENa was significantly greater in
transplant recipients and in one-kidney controls with a lower
GFR. V was not significantly altered during amino acid infu-
sion. In contrast, UNaV increased by 100 23 (P < 0.001), 110
52(P <0.05), 95 29(P <0.01) and 110 23 tmolJmin(P <
0.001) in R at Si and S2, UNx.C and 2K.C, respectively,
whereas Cosm increased by 1.4 0.2 (P < 0.001), 1.5 0.5
(P < 0.01), 1.0 0.3 (P < 0.05) and 1.2 0.2 mLlmin (P <
0.001), respectively. FENa also increased in recipients and
controls but the difference with baseline values was only
significant in 2K.C (0.20 0.09%, P < 0.05). CH20 tended to
decrease consistently in both controls and recipients although
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Baseline Stimulation Recovery
Renin ng/liter
R-Sl 14.4 2.8 13.0 2.3 11.7 2.2
R-S2 12.9 3.1 9.5 l.8a 8.3 l.7
UNx.C 13.2 1.3 11.4 1.8 9.8 2.4
2K.C 12.4 2.2 9.3 l.9a 8.7 14b
Aldosterone ng/d!
R-Sl 12,4 2.8 7.6 0.9 16.9 4.6
R-S2 17.8 4.3 14.6 3.7 19.7 6.0
UNx.C 15.3 1.4 12.6 3.5 14.8 1.0
2K.C 14.7 1.7 10.3 1.3 10.9 1.7
0.05). Amino acid-induced alterations were in the same direc-
tion in transplant recipients and in controls. In Rat Si, Rat S2,
UNx.C and 2K.C, respectively, they consisted of significant
increases in CL, (8 2 mI/mm, P < 0.001; 12 3 milmin, P <
0.01; 12 2 mLlmin, P < 0.001; and 16 2 mL/min, P < 0.001),
in FELl (5.3 2.8%, P < 0.05; 6.0 3.0%, P < 0.05; 5.3
1.6%, P < 0.01; and 4.8 1.4%, P < 0.01), and in APR (9.0
2.2 ml/min, P < 0.05; 5.1 1.9 mi/mm, P < 0.05; 6.3 2.6
mi/mm, P < 0.05; and 11.6 2.9 mi/mm, P < 0.01). No
significant difference in CLI, FELl and APR was observed
between baseline and recovery values in transplant recipients
or in controls.
It is also noteworthy that neither plasma renin nor aldoste-
rone levels differed between recipients and controls during
baseline periods (Table 4). Plasma renin concentration exhib-
ited a tendency to decline throughout the study. During amino
acid infusion, this decrease was significant in recipients at S2
(3.4 1.6 ng/liter, P < 0.05) and in 2K.C (3.0 1.4 ng/liter, P <
0.05) but not in recipients at Si (1.4 0.9 ng/liter) nor in UNx.C
(1.8 1.4 ng/liter). Although, aldosterone concentration also
tended to decline during amino acid stimulation, its decrease
was not significant in recipients at Si and S2 nor in UNx and 2K
controls.
Discussion
This study documents specific characteristics of the renal
functional reserve induced by an amino acid infusion in renal
transplant recipients submitted to cyclospormn therapy when
compared with one- and two-kidney control subjects. Our
observations provide new information on three points. (1)
Transplant recipients do have a renal functional reserve in the
first month after transplantation and in the eighth. RFR in
transplant recipients is not reduced in proportion to baseline
GFR and is even higher than in controls when expressed as a
percentage increase of baseline values. (2) Baseline fractional
proximal excretion (calculated from the clearance of lithium) is
not reduced; on the contrary, it is even greater in recipients, as
well as in one-kidney controls, than in two-kidney subjects. (3)
In both transplant recipients and controls, the acute increase in
GFR induced by amino acids involves no reduction in proximal
Table 4. Effects of AA infusion (stimulation) on plasma active renin
and aldosterone concentrations in kidney recipients I month (R-Sl) and
8 months (R-S2) after transplantation, in uninephrectomized controls
(UNx.C), and in healthy two-kidney controls (2K.C)
Values are expressed as means SE.
a P < 0.05 vs. Baseline
b P < 0.01 vs. Baseline
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Fig. 3. Clearance of lithium (CL1), fractional lithium excretion (FELl)
and absolute proximal reabsorption (APR) before (baseline: •), during(stimulated higher GFR: 0) and after (recovery: ) amino acid
infusion in 12 renal transplant recipients either 20.0 2.5 days (R-S1)
or 7.6 0.4 months (R-S2) after transplantation, in 8 uninephrecto-
mized controls (UNx.C), and in 12 healthy two-kidney controls (2K.C).
Values represent means SE. Circles represent significant differences
compared to baseline 2K.C values (0 P < 0.05, 000 P < 0.001).
Asterisks represent significant differences compared to respective base-
line values (* P < 0.05, ** p < 0.01, P < 0.001).
the difference with respective baseline values was not signifi-
cant.
Baseline lithium clearance was significantly lower in recipi-
ents at Si and S2 (P < 0.001) and in UNx.C (P < 0.05) than in
2K.C (Fig. 3). Baseline absolute proximal reabsorption was also
lower in R and UNx.C (P < 0.001). Nevertheless, baseline
fractional excretion of lithium was significantly higher in recip-
ients and one-kidney controls than in two-kidney controls (P <
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tubule outflow in spite of the expected increase in proximal
tubule reabsorption.
Renal transplant recipients treated with cyclosporin have a
stable RFR during the first months after transplantation. In
spite of much higher renal vascular resistances, RFR in graft
recipients represents approximately 30 and 31% of baseline
GFR, respectively at one and eight months, and is greater than
in one- and two-kidney controls (25%). Changes in daily aza-
thioprine, prednisone or cyclosporin dosage had no influence on
renal hemodynamics in recipients because neither baseline
GFR, ERPF and RVR nor the response to amino acids signifi-
cantly differed between Si and S2. Although several recipients
were receiving calcium inhibitor antihypertensive medication—
which may, in theory, affect renal resistances and prevent the
deleterious effect of cyclosporin on the kidney [27—30]—these
patients do not differ from the group as a whole nor from
normotensive recipients in the response of GFR to amino acid
stimulation. Previous studies have failed to detect any RFR in
cyclosporin-treated kidney recipients when using either an oral
protein load [8, 91 or an infusion of an amino acid solution [10,
11]. Differences in experimental conditions may have contrib-
uted to the divergent findings since a large number of factors
such as sodium balance, the degree of activation of the renin-
angiotensin system, protein intake prior to the test, the oral or
i.v. administration of acute protein load, and the methods used
to measure GFR and ERPF may greatly influence the results [7,
31, 32]. These variables were taken into consideration and
sodium and protein intakes were standardized prior to our
study. Thus, controls and recipients at Si and S2 were in the
same sodium and protein balance as demonstrated by similar
urinary sodium excretion, plasma renin and aldosterone levels,
and urinary urea nitrogen excretion. In addition, clearances
were measured by an accurate constant infusion method using
inulin and p-amino hippurate for estimating GFR and ERPF,
respectively. Finally, the discrepancy in results may also be
related to differences in the interval between transplantation
and RFR testing and in the duration of cyclosporin treatment.
In the previous studies, this interval was either unprecisely
stated as at least three months [8, 10] or very heterogeneous:
seven to 34 months [9] and nine to 85 months Eli]. In contrast,
we documented RFR at two post-transplantation times as
precisely defined as possible.
It is generally agreed that the existence of a RFR indicates
that all nephrons are not functioning at their maximal degree
and that the kidneys do not exhibit permanent glomerular
hyperfiltration. Our results indicate that this assertion applies to
the transplanted kidney submitted to cyclosporin. This result
may seem surprising because, whatever the mechanisms, cy-
closporin is known to induce by itself a renal vasoconstriction,
an increase in RVR, and a concomitant reduction in GFR and
RBF [27, 33, 34]. Several lines of evidence have indicated that
the afferent arteriole and/or the glomerular mesangial cell is/are
the major intrarenal targets for cyclosporin and that the in-
crease in RVR is predominantly due to preglomerular vasocon-
striction [1, 27, 33—36]. The data in this study clearly indicate
that: first, cyclosporin has a vasoconstrictive action as evi-
denced by the significantly lower baseline GFR and higher
baseline renal resistances in transplanted kidneys at Si and S2
than in UNx controls' remaining kidney; second, that the
graft's ability to vasodilate and to demonstrate a RFR in
response to an amino acid infusion is nevertheless not sup-
pressed, at least until eight months after transplantation; and
third, that there is a degree of irreversible GFR reduction in
addition, as indicated by the fact that the GFR in cyclosporin-
treated recipients remained lower than in UNx controls during
amino acid infusion. Thus, the deleterious effect of cyclosporin
on GFR is partly reversible in this period of time.
Our studies demonstrate striking differences between recipi-
ents' and control subjects' hemodynamic response to amino
acids. In both UNx and 2K controls, the acute increase in GFR
occurred with no significant alteration in ERPF and thus with an
increase in filtration fraction. The decreases in RVR were
approximately i3 and 12%, respectively. In both controls, a
significant inverse correlation was observed between RFR and
baseline GFR. These results confirm previous reports in normal
kidneys [7] that the greater the resting GFR, the lower the acute
increase induced by a protein load. This suggests that there are
wide normal differences in basal tone of glomerular arterioles in
healthy kidneys and that the capacity for additional vasodilation
is strictly dependent on the basal hemodynamic conditions. In
striking contrast, the acute increase in GFR induced by amino
acids in recipients at both Sl and S2 occurred with a significant
increase in ERPF, thus with no alteration in filtration fraction,
and with a larger decrease in RVR (approximately 20 and 17%
at S 1 and S2, respectively). In addition, no significant correla-
tion between RFR and baseline GFR could be detected at one
or at eight months after transplantation indicating that, contrary
to healthy kidneys, RFR could not be predicted from resting
GFR.
It is worth pointing out that renal hemodynamic responses to
amino acid infusion in two-kidney healthy volunteers and in
one-kidney subjects previously subjected to uninephrectomy
are basically similar and both very different to that of recipients.
The one-kidney controls were studied approximately nine
months after they underwent uninephrectomy, that is, in the
same time-range as the interval between transplantation and the
second study in recipients. As indicated by the results of
previous studies on RFR in one-kidney subjects, carried out at
various times after uninephrectomy [37, 38], the remnant kid-
ney in our UNx controls had probably not yet undergone all of
its compensatory rises in GFR and ERPF at this time. How-
ever, this allows a relevant comparison with our transplanted
patients. The differences between recipients and UNx controls
justify the interpretation that the special response of the trans-
planted kidney is not related to a one-kidney condition. The fact
that the transplanted kidney is denervated whereas the remnant
kidney is innervated is, however, an important difference
between R and UNx.C. Because cyclosporin-induced renal
alterations may be mediated, at least in part, by an excessive
adrenergic nerve stimulation [39, 401, this difference is not
likely to explain the special hemodynamic features in trans-
planted patients. On the contrary, denervation may have partly
protected the grafted kidney from cyclosporin effect and have
tended to reduce the differences between R and UNx controls.
Clearly, recipients treated with cyclosporin have both an im-
portant RFR and very special hemodynamic features. The renal
capacity to achieve a higher degree of function by vasodilation
of glomerular arterioles exists but the magnitude of the re-
sponse is independent of the reduced GFR and the increased
renal resistances.
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A carefully designed study in hypertensive patients trans-
planted six to 72 months beforehand and not treated with
cyclosporin previously failed to detect any GFR response to an
acute protein intake [32]. However, a clear response was
restored after four and 12 months of angiotensin converting
enzyme (ACE)-inhibition therapy with fosinopril, although it
also markedly decreased baseline GFR. The authors have
reasonably suggested that the ACE inhibitor produced a pref-
erential efferent arteriolar dilation and a reduction in intraglom-
erular pressure. They hypothetized that the lower level of GFR
induced by fosinopril represents a more physiological state,
without glomerular hypertension and compatible with the res-
toration of a RFR in response to acute protein intake [32].
Moreover, a long-term treatment with the ACE inhibitor lisino-
pril was able to decrease the filtration fraction in hypertensive
recipients maintained on cyclosporin whereas the calcium an-
tagonist nifedipine was not [29]. In the same way, an a
posteriori comparison between patients who took cyclosporin
and those who did not in a group of kidney recipients examined
at heterogeneous intervals after transplantation indicated that
the former had a lower baseline GFR, and that their increase in
GFR in response to amino acid infusion was not statistically
significant unless they received an i.v. injection of perindoprilat
prior to amino acids [11]. The data of these studies suggest that
the decrease in RVR induced by ACE inhibitor is preferentially
located at the efferent glomerular level and may result in a
decreased intraglomerular capillary pressure. These previous
reports and the very particular pattern of the hemodynamic
response that we observed strongly suggest a new interpreta-
tion of the relationship between cyclosporin and renal func-
tional reserve. The increase in GFR and decrease in RVR are
proportionally greater, and RFR is not predictable from basal
GFR in recipients as it is in controls. Therefore, the cyclospor-
in-induced reversible preglomerular vasoconstriction also
seems to be efficient by reducing glomerular capillary pressure
and/or flow as did (through a different mechanism) ACE inhi-
bition therapy in the aforementioned studies. Both cyclosporin
and ACE inhibitors could possibly maintain a similar ratio
between pre- and postglomerular vascular tone, the former by
constricting afferent arterioles and the latter by dilating efferent
arterioles. In spite of its nephrotoxicity, cyclosporin would thus
protect the graft from permanent hyperfiltration through a
rather paradoxical mechanism, that is, by increasing preglom-
erular resistance and decreasing basal GFR. Whether or not this
effect may protect the renal graft from glomerular changes
induced by hyperfiltration and lengthen its subsequent survival
remains to be shown. Previous detailed studies of the long-term
evolution of renal function during cyclosporin therapy have
provided very conflicting results but, interestingly, recent stud-
ies in patients submitted to lower dosage have rather demon-
strated a more stable renal function [1, 41—44]. Repeated
evaluation of the RFR may allow conclusive new insights to be
gained on the subject.
To our knowledge, the clearance of lithium has never been
used in recipients on cyclosporin therapy to examine the
intrarenal mechanism brought into play during elicitation of the
RFR. Interpretation of the tubular function data is based on the
assumption that lithium is reabsorbed like sodium and water in
the proximal tubule and then passes through the distal segments
without significant reabsorption, that is, that the CLI is an
accurate marker of overall proximal fluid delivery to the distal
nephron [45, 46]. Although this postulate cannot be accepted
without reservation [46], available information suggests that the
CLI can be used with some degree of confidence in the current
study and that its values give realistic and comparative esti-
mates of proximal fluid delivery to the loops of Henle because:
1) transplanted patients and healthy subjects were on normal
and similar sodium diet at least one week prior to the studies
and were in euvolemic conditions; (2) baseline urine flow rate,
urinary sodium excretion, osmolar clearance and free water
clearance did not differ significantly between controls and
recipients at S 1 or S2; and (3) no significant difference in CLI,
FELl and APR was observed between baseline and recovery
values in controls or in graft recipients. However, it must be
conceded that an effect of test substances on lithium handling
by distal nephron segments cannot be excluded.
Our results indicate that the baseline fractional excretion of
lithium, prior to amino acid infusion, is not lower but signifi-
cantly greater in recipients at Si and S2 and in UNx controls
than in two-kidney healthy subjects. This means that the
baseline clearance of lithium, estimating absolute proximal
outflow, is proportionally less reduced than GFR in R and
UNx.C, thus indicating a baseline fractional decrease in prox-
imal reabsorption. It may be considered as a normal adaptation
of glomerulo-tubular balance to the reduction in nephron num-
ber as indicated by the fact that baseline FEL, is similarly
increased above that of two-kidney controls in recipients as
well as in uninephrectomized subjects, both with one available
kidney. Our lithium clearance results in R and UNx.C are in
agreement with previous micropuncture studies in rats, either
on a transplanted kidney or on an in situ kidney with the
contralateral kidney removed [47, 48]. Both studies reported an
increase in late proximal tubule fluid flow. The concomitant
increase in the tubular perfusion rate required for a half-
maximal suppression of proximal tubule stop-flow pressure
therefore indicated a resetting of the tubuloglomerular feedback
because the single nephron GFR in the remaining transplanted
[47] or in situ kidney [48] was allowed to rise in spite of the
increased late proximal tubule fluid flow. In recipients, in-
creased fractional proximal outflow may have contributed to
the observed maintenance of normal sodium balance and base-
line values of urinary excretion in spite of the lower GFR.
Several previous studies using lithium clearance, occlusion
time/transit time and/or micropuncture methods in rats [23, 24]
and the lithium clearance method in humans [25, 26] have
suggested that cyclosporin may decrease proximal tubule out-
flow to a higher degree than GFR and may thus elicit a decrease
in FELl. Experimental conditions were, however, very different
from ours in the above-mentioned studies conducted in hu-
mans, particularly regarding the treatment with cyclosporin and
the renal functional evaluation. Clearance measurements were
performed either before and after four days of cyclosporin in
nine kidney transplant recipients [26] or before and after a mean
of 41 days of cyclosporin (range 21 to 133 days) in nine patients,
with previously normal renal function, given cyclosponn in the
treatment of ocular manifestations of extrarenal diseases or of
bone marrow transplantation [25]. In both studies, the cyclo-
sporin dosage used was greater than ours: 8 to 12 [26] and 7.9
mg/kg/day [25]. GFR was evaluated either only by creatinine
clearance [26] or by a simplified single injection method [25]. In
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contrast, we performed renal functional evaluation by a con-
stant infusion method in uninephrectomized and two-kidney
controls and in 12 kidney transplant recipients after 20 days and
eight months of lower doses of cyclosporin, with all groups in
similar sodium and protein balance and with similar plasma
renin and aldosterone levels. Our results clearly indicate that
baseline fractional proximal reabsorption in cyclosporin treated
kidney transplant recipients and in one-kidney controls is lower
than in healthy two-kidney controls under these conditions, and
that proximal reabsorption has no tendency to increase with the
extension of cyclosporin treatment up to at least eight months
after transplantation.
Our studies provide new evidence in transplant recipients as
well as in both controls that the acute increase in GFR induced
by amino acids involves no reduction in proximal tubule out-
flow. Several experimental studies previously carried out on
animals have suggested that one of the likely mechanisms
involved during an induced acute hyperfiltration or a long-
lasting protein-rich diet might be an increased reabsorption
upstream of the macula densa, a decreased activity of the
tubuloglomerular feedback and, finally, a preglomerular vaso-
dilation allowing GFR to rise [6, 17—20]. Our results confirm
previous reports that both a protein-rich meal [49, 50] and an
infusion of amino acids [51] elicit an acute increase in lithium
clearance and in fractional lithium excretion together with the
expected increase in GFR, as observed in one- and two-kidney
control subjects. Moreover, our lithium clearance results in
recipients during amino acid infusion are basically similar to
those obtained in controls. Our results therefore indicate that an
increase in proximal reabsorption actually occurs during an
induced hyperfiltration in recipients as well as in controls, but is
proportionally lower than that in GFR and does not prevent
proximal tubule outflow from rising. Along with the recipients'
high baseline fractional excretion of lithium, this similarity
between recipients and controls also confirms that cyclosporin
treatment did not significantly alter proximal tubule function in
our transplanted patients. Our results do not, of course, rule out
the possibility that a normal proximal tubule reabsorptive
function is absolutely necessary for the stimulated increase in
GFR to occur, as evidenced in dogs with experimental Fanconi
syndrome or infused with a diuretic drug known to impair
proximal reabsorption whose normal renal responses to acute
protein feeding were blocked [20].
Nor do our data rule out the hypothesis that a tubuloglomer-
ular feedback mechanism may be involved in mediating the
renal hemodynamic response. Indeed, they merely indicate that
proximal tubule outflow increases, and that neither in one- and
two-kidney controls nor in transplant recipients can it be
considered that an increased proximal reabsorptive activity is
responsible for any possible reduction in the signal at the
macula densa and in the negative feedback control on glomer-
ular hemodynamics. If effective, reductions in this signal and
this feedback control would rather imply an increased reabsorp-
tion in the tubular segments between late proximal tubule and
the macula densa. A micropuncture and microperfusion study
in rats has previously demonstrated that a chronic high protein
diet induces higher rates of sodium chloride absorption between
the late proximal and early distal tubules [17]. A morphologic
and functional study has also demonstrated that such a diet
elicits a preferential increase in thickness of the inner stripe of
the outer medulla and a marked hypertrophy of the thick
ascending limbs in this stripe [19]. Interestingly, these high
protein-fed rats also exhibited a sustained stimulation of urine
concentrating process and a dramatic increase in free water
reabsorption indicating that alterations in thick ascending limb
morphology and function were linked [19]. It is noteworthy that
our data in both controls and recipients tie up with the results of
these chronic studies, since we detected in all groups a consis-
tent, although not significant, decrease in free water clearance
even during the transient hyperfiltration elicited by amino acid
loading and while osmolar clearance was significantly increas-
ing. Moreover, a study in healthy volunteers has recently
pointed out that ingestion of a protein meal, which induces a
consistent acute hyperfiltration, increases plasma vasopressin
concentration and free water reabsorption when hydration is
not raised to supraphysiological levels, whereas high hydration
blunts the post-prandial increase in GFR [52]. These results and
ours suggest that an increased reabsorption may, nonetheless,
take place between the late proximal tubule and macula densa
during an acute induced hyperfiltration to alter the tubuloglom-
erular feedback mechanism.
We conclude that, even when maintained on cyclosporin
therapy, renal transplant recipients do have a renal functional
reserve both one month and eight months post-transplantation
and do not exhibit permanent glomerular hyperfiltration. RFR
represents approximately 30% of the baseline GFR and is one
element of a particular pattern of hemodynamic response to
amino acid stimulation. The results favor the interpretation of a
partially-reversible preglomerular vasoconstrictive effect of cy-
closporin on the graft that might prevent glomerular hyperfil-
tration. The baseline fractional excretion of lithium is greater in
transplant recipients than in healthy two-kidney subjects as it is
in one-kidney controls, indicating that cyclosporin did not
increase proximal reabsorption in our transplanted patients.
The acute increase in GFR during amino acid infusion, whether
in recipients or in controls, is not associated with a reduction in
proximal tubule outflow that could account for any possible
reduction in the tubuloglomerular feedback activity.
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